Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (977)	8/8/2002 9:46:36 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1834

His own incident "put a damper on my phone conversations with doctors I don't know," he says It's OK if a few patients don't get into a trial who would otherwise be there, correct? It's only cancer.

To: mopgcw who wrote (977)	8/8/2002 10:57:20 AM
From: scaram(o)uche	Respond to of 1834

>> By GEETA ANAND and RANDALL SMITH << Oh, geeeeeeze, she's on CNBC now. She's drop-dead gorgeous. Hey, Geeta, if you're reading this....... is your mom single????

To: mopgcw who wrote (977)	8/9/2002 12:01:12 PM
From: Hawkmoon	Respond to of 1834

Thanks for posting that!! Saw Ted David rip into the analyst from Sterling this morning... A beautiful thing to behold. Hawk

To: mopgcw who wrote (977)	3/3/2004 9:56:09 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1834

>> Mr. Risk says he didn't know the patient had tested positive for opiates or that doctors weren't blaming the Neurocrine drug. He didn't check with Neurocrine before putting out the report, the 25-year-old analyst says, adding that he doesn't believe it's essential to call companies before attacking or lauding their products. "I'm young and inexperienced and not afraid to be wrong," he says. << State of art, world of Sterling, Fulcrum, Avalon et al. (IMO) research, 1.5 years ago.